Pages that link to "Item:Q3837320"
From MaRDI portal
The following pages link to Consistency of continual reassessment method under model misspecification (Q3837320):
Displayed 21 items.
- A note on the robustness of the continual reassessment method (Q433569) (← links)
- On the consistency of the continual reassessment method with multiple toxicity constraints (Q499432) (← links)
- The treatment versus experimentation dilemma in dose finding studies (Q538132) (← links)
- Stochastic approximation and modern model-based designs for dose-finding clinical trials (Q903289) (← links)
- Convergence properties of sequential Bayesian \(D\)-optimal designs (Q958799) (← links)
- Bayesian data augmentation dose finding with continual reassessment method and delayed toxicity (Q2441853) (← links)
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- Theoretical study of the continual reassessment method (Q2492919) (← links)
- Dose-Finding Designs for HIV Studies (Q3078854) (← links)
- On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance (Q3078934) (← links)
- Curve-Free and Model-Based Continual Reassessment Method Designs (Q3078936) (← links)
- A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method (Q3079010) (← links)
- Continual Reassessment Method for Ordered Groups (Q3079132) (← links)
- Dynamic calibration of pharmacokinetic parameters in dose-finding studies (Q3303574) (← links)
- Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities (Q4670477) (← links)
- (Q4998881) (← links)
- (Q5072154) (← links)
- A new design of the continual reassessment method (Q5082671) (← links)
- A study of the probit model with latent variables in Phase I clinical trials (Q5220814) (← links)
- Retrospective Analysis of Sequential Dose‐Finding Designs (Q5717156) (← links)
- Performance Measures in Dose‐Finding Experiments (Q6085864) (← links)